$SANA
Sana Biotechnology, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Seattle, WA
SANA chart
What traders are saying about $SANA
Latest postsSana Biotechnology, Inc. news
- Sana Biotechnology, Inc. Estimates – NASDAQ:SANA
TradingView ·
- Sana Biotechnology to Present at September 2026 Investor Conferences
Yahoo Finance ·
- Paratus Sciences Announces Updates to its Board of Directors
Yahoo Finance ·
- Sana Biotechnology Reports Second Quarter 2026 Financial Results and Business Updates
Yahoo Finance ·
- 3 Promising Genomics Stocks to Add to Your Portfolio in 2026
Yahoo Finance ·
- Sana Biotechnology (SANA) Publishes 14 Month Diabetes Cell Therapy Results In NEJM
Yahoo Finance ·
- Sana (SANA) Upgraded to Buy: Here's What You Should Know
Yahoo Finance ·
- Sana Biotechnology Announces Follow-On Publication in The New England Journal of Medicine (NEJM) Highlighting Groundbreaking Long-Term Data and Durability of Hypoimmune-Modified Islet Cell Transplantation Without Immunosuppression in Type 1 Diabetes
Yahoo Finance ·
- Sana Biotechnology Announces Symposium Presentation at the European Association for the Study of Diabetes (EASD) Annual Meeting 2026
Yahoo Finance ·
- ‘I worry deeply about bioterrorism’: Is Europe sufficiently prepared for another pandemic?
euronews.com ·
- Harbour BioMed Appoints Dr. Dhavalkumar Patel as Scientific Advisor
Yahoo Finance ·
- Sana Biotechnology to Present at June 2026 Investor Conferences
Yahoo Finance ·
Sana Biotechnology, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$244.2M | -$266.8M | -$283.3M | -$269.5M |
| Diluted EPS | $-0.96 | $-1.16 | $-1.46 | $-1.43 |
| Total assets (year end) | $416.9M | $501.0M | $565.3M | $822.7M |
| Cash and equivalents (year end) | $71.9M | $127.6M | $133.5M | $176.8M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Sana Biotechnology, Inc.
- Ticker
- SANA (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Seattle, WA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1770121
Frequently asked questions
What exchange is Sana Biotechnology, Inc. listed on?
Sana Biotechnology, Inc. trades on the Nasdaq under the ticker symbol SANA.
What industry is Sana Biotechnology, Inc. in?
Sana Biotechnology, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Sana Biotechnology, Inc. headquartered?
Sana Biotechnology, Inc.'s business address on file with the SEC is in Seattle, WA.
When does Sana Biotechnology, Inc.'s fiscal year end?
Sana Biotechnology, Inc.'s fiscal year ends on December 31.